E-Prescribing Market (By Product: Solutions, Services; By Delivery Mode; By End-use; By Usage Methods; By Substances; By Specialties) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Specialties Procurement Analysis 

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on E-Prescribing Market 

5.1. COVID-19 Landscape: E-Prescribing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global E-Prescribing Market, By Product

8.1. E-Prescribing Market, by Product, 2023-2032

8.1.1. Solutions

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Services

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global E-Prescribing Market, By Delivery Mode

9.1. E-Prescribing Market, by Delivery Mode, 2023-2032

9.1.1. Web/Cloud-Based

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. On-premise

9.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global E-Prescribing Market, By End-use

10.1. E-Prescribing Market, by End-use, 2023-2032

10.1.1. Hospital

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Office-based Physicians

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Pharmacy

10.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global E-Prescribing Market, By Usage Methods

11.1. E-Prescribing Market, by Usage Methods, 2023-2032

11.1.1. Handheld

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Computer Based Devices

11.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global E-Prescribing Market, By Substances

12.1. E-Prescribing Market, by Substances, 2023-2032

12.1.1. Controlled Substances

12.1.1.1. Market Revenue and Forecast (2020-2032)

12.1.2. Non-controlled Substances

12.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 13. Global E-Prescribing Market, By Specialties

13.1. E-Prescribing Market, by Specialties, 2023-2032

13.1.1. Oncology

13.1.1.1. Market Revenue and Forecast (2020-2032)

13.1.2. Sports Medicine

13.1.2.1. Market Revenue and Forecast (2020-2032)

13.1.3. Neurology

13.1.3.1. Market Revenue and Forecast (2020-2032)

13.1.4. Cardiology

13.1.4.1. Market Revenue and Forecast (2020-2032)

13.1.5. Others

13.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 14. Global E-Prescribing Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Product (2020-2032)

14.1.2. Market Revenue and Forecast, by Delivery Mode (2020-2032)

14.1.3. Market Revenue and Forecast, by End-use (2020-2032)

14.1.4. Market Revenue and Forecast, by Usage Methods (2020-2032)

14.1.5. Market Revenue and Forecast, by Substances (2020-2032)

14.1.6. Market Revenue and Forecast, by Specialties (2020-2032)

14.1.7. U.S.

14.1.7.1. Market Revenue and Forecast, by Product (2020-2032)

14.1.7.2. Market Revenue and Forecast, by Delivery Mode (2020-2032)

14.1.7.3. Market Revenue and Forecast, by End-use (2020-2032)

14.1.7.4. Market Revenue and Forecast, by Usage Methods (2020-2032)

14.1.8. Market Revenue and Forecast, by Substances (2020-2032)

14.1.8.1. Market Revenue and Forecast, by Specialties (2020-2032) 

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Product (2020-2032)

14.1.9.2. Market Revenue and Forecast, by Delivery Mode (2020-2032)

14.1.9.3. Market Revenue and Forecast, by End-use (2020-2032)

14.1.9.4. Market Revenue and Forecast, by Usage Methods (2020-2032)

14.1.10. Market Revenue and Forecast, by Substances (2020-2032)

14.1.11. Market Revenue and Forecast, by Specialties (2020-2032)

14.1.11.1.

14.2. Europe

14.2.1. Market Revenue and Forecast, by Product (2020-2032)

14.2.2. Market Revenue and Forecast, by Delivery Mode (2020-2032)

14.2.3. Market Revenue and Forecast, by End-use (2020-2032)

14.2.4. Market Revenue and Forecast, by Usage Methods (2020-2032) 

14.2.5. Market Revenue and Forecast, by Substances (2020-2032)

14.2.6. Market Revenue and Forecast, by Specialties (2020-2032)

14.2.7.

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Product (2020-2032)

14.2.8.2. Market Revenue and Forecast, by Delivery Mode (2020-2032)

14.2.8.3. Market Revenue and Forecast, by End-use (2020-2032)

14.2.9. Market Revenue and Forecast, by Usage Methods (2020-2032) 

14.2.10. Market Revenue and Forecast, by Substances (2020-2032)

14.2.10.1. Market Revenue and Forecast, by Specialties (2020-2032) 

14.2.11. Germany

14.2.11.1. Market Revenue and Forecast, by Product (2020-2032)

14.2.11.2. Market Revenue and Forecast, by Delivery Mode (2020-2032)

14.2.11.3. Market Revenue and Forecast, by End-use (2020-2032)

14.2.12. Market Revenue and Forecast, by Usage Methods (2020-2032)

14.2.13. Market Revenue and Forecast, by Substances (2020-2032)

14.2.14. Market Revenue and Forecast, by Specialties (2020-2032)

14.2.14.1.

14.2.15. France

14.2.15.1. Market Revenue and Forecast, by Product (2020-2032)

14.2.15.2. Market Revenue and Forecast, by Delivery Mode (2020-2032)

14.2.15.3. Market Revenue and Forecast, by End-use (2020-2032)

14.2.15.4. Market Revenue and Forecast, by Usage Methods (2020-2032)

14.2.16. Market Revenue and Forecast, by Substances (2020-2032)

14.2.16.1. Market Revenue and Forecast, by Specialties (2020-2032)

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Forecast, by Product (2020-2032)

14.2.17.2. Market Revenue and Forecast, by Delivery Mode (2020-2032)

14.2.17.3. Market Revenue and Forecast, by End-use (2020-2032)

14.2.17.4. Market Revenue and Forecast, by Usage Methods (2020-2032)

14.2.18. Market Revenue and Forecast, by Substances (2020-2032)

14.2.18.1. Market Revenue and Forecast, by Specialties (2020-2032)

14.3. APAC

14.3.1. Market Revenue and Forecast, by Product (2020-2032)

14.3.2. Market Revenue and Forecast, by Delivery Mode (2020-2032)

14.3.3. Market Revenue and Forecast, by End-use (2020-2032)

14.3.4. Market Revenue and Forecast, by Usage Methods (2020-2032)

14.3.5. Market Revenue and Forecast, by Substances (2020-2032)

14.3.6. Market Revenue and Forecast, by Specialties (2020-2032)

14.3.7. India

14.3.7.1. Market Revenue and Forecast, by Product (2020-2032)

14.3.7.2. Market Revenue and Forecast, by Delivery Mode (2020-2032)

14.3.7.3. Market Revenue and Forecast, by End-use (2020-2032)

14.3.7.4. Market Revenue and Forecast, by Usage Methods (2020-2032)

14.3.8. Market Revenue and Forecast, by Substances (2020-2032)

14.3.9. Market Revenue and Forecast, by Specialties (2020-2032)

14.3.10. China

14.3.10.1. Market Revenue and Forecast, by Product (2020-2032)

14.3.10.2. Market Revenue and Forecast, by Delivery Mode (2020-2032)

14.3.10.3. Market Revenue and Forecast, by End-use (2020-2032)

14.3.10.4. Market Revenue and Forecast, by Usage Methods (2020-2032)

14.3.11. Market Revenue and Forecast, by Substances (2020-2032)

14.3.11.1. Market Revenue and Forecast, by Specialties (2020-2032)

14.3.12. Japan

14.3.12.1. Market Revenue and Forecast, by Product (2020-2032)

14.3.12.2. Market Revenue and Forecast, by Delivery Mode (2020-2032)

14.3.12.3. Market Revenue and Forecast, by End-use (2020-2032)

14.3.12.4. Market Revenue and Forecast, by Usage Methods (2020-2032)

14.3.12.5. Market Revenue and Forecast, by Substances (2020-2032)

14.3.12.6. Market Revenue and Forecast, by Specialties (2020-2032)

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Forecast, by Product (2020-2032)

14.3.13.2. Market Revenue and Forecast, by Delivery Mode (2020-2032)

14.3.13.3. Market Revenue and Forecast, by End-use (2020-2032)

14.3.13.4. Market Revenue and Forecast, by Usage Methods (2020-2032)

14.3.13.5. Market Revenue and Forecast, by Substances (2020-2032)

14.3.13.6. Market Revenue and Forecast, by Specialties (2020-2032)

14.4. MEA

14.4.1. Market Revenue and Forecast, by Product (2020-2032)

14.4.2. Market Revenue and Forecast, by Delivery Mode (2020-2032)

14.4.3. Market Revenue and Forecast, by End-use (2020-2032)

14.4.4. Market Revenue and Forecast, by Usage Methods (2020-2032)

14.4.5. Market Revenue and Forecast, by Substances (2020-2032)

14.4.6. Market Revenue and Forecast, by Specialties (2020-2032)

14.4.7. GCC

14.4.7.1. Market Revenue and Forecast, by Product (2020-2032)

14.4.7.2. Market Revenue and Forecast, by Delivery Mode (2020-2032)

14.4.7.3. Market Revenue and Forecast, by End-use (2020-2032)

14.4.7.4. Market Revenue and Forecast, by Usage Methods (2020-2032)

14.4.8. Market Revenue and Forecast, by Substances (2020-2032)

14.4.9. Market Revenue and Forecast, by Specialties (2020-2032)

14.4.10. North Africa

14.4.10.1. Market Revenue and Forecast, by Product (2020-2032)

14.4.10.2. Market Revenue and Forecast, by Delivery Mode (2020-2032)

14.4.10.3. Market Revenue and Forecast, by End-use (2020-2032)

14.4.10.4. Market Revenue and Forecast, by Usage Methods (2020-2032)

14.4.11. Market Revenue and Forecast, by Substances (2020-2032)

14.4.12. Market Revenue and Forecast, by Specialties (2020-2032)

14.4.13. South Africa

14.4.13.1. Market Revenue and Forecast, by Product (2020-2032)

14.4.13.2. Market Revenue and Forecast, by Delivery Mode (2020-2032)

14.4.13.3. Market Revenue and Forecast, by End-use (2020-2032)

14.4.13.4. Market Revenue and Forecast, by Usage Methods (2020-2032)

14.4.13.5. Market Revenue and Forecast, by Substances (2020-2032)

14.4.13.6. Market Revenue and Forecast, by Specialties (2020-2032)

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Forecast, by Product (2020-2032)

14.4.14.2. Market Revenue and Forecast, by Delivery Mode (2020-2032)

14.4.14.3. Market Revenue and Forecast, by End-use (2020-2032)

14.4.14.4. Market Revenue and Forecast, by Usage Methods (2020-2032)

14.4.14.5. Market Revenue and Forecast, by Substances (2020-2032)

14.4.14.6. Market Revenue and Forecast, by Specialties (2020-2032)

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Product (2020-2032)

14.5.2. Market Revenue and Forecast, by Delivery Mode (2020-2032)

14.5.3. Market Revenue and Forecast, by End-use (2020-2032)

14.5.4. Market Revenue and Forecast, by Usage Methods (2020-2032)

14.5.5. Market Revenue and Forecast, by Substances (2020-2032)

14.5.6. Market Revenue and Forecast, by Specialties (2020-2032)

14.5.7. Brazil

14.5.7.1. Market Revenue and Forecast, by Product (2020-2032)

14.5.7.2. Market Revenue and Forecast, by Delivery Mode (2020-2032)

14.5.7.3. Market Revenue and Forecast, by End-use (2020-2032)

14.5.7.4. Market Revenue and Forecast, by Usage Methods (2020-2032)

14.5.8. Market Revenue and Forecast, by Substances (2020-2032)

14.5.8.1. Market Revenue and Forecast, by Specialties (2020-2032)

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Product (2020-2032)

14.5.9.2. Market Revenue and Forecast, by Delivery Mode (2020-2032)

14.5.9.3. Market Revenue and Forecast, by End-use (2020-2032)

14.5.9.4. Market Revenue and Forecast, by Usage Methods (2020-2032)

14.5.9.5. Market Revenue and Forecast, by Substances (2020-2032)

14.5.9.6. Market Revenue and Forecast, by Specialties (2020-2032)

Chapter 15. Company Profiles

15.1. Cerner Corporation (Oracle)

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Allscripts Healthcare LLC

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Epic Systems Corporation

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. DrFirst

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Athenahealth

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. NXGN Management LLC

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. McKesson Corporation

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Surescripts

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Change Healthcare

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Practice Fusion, Inc.

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms